WASHINGTON--(BUSINESS WIRE)--Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement following passage by the House of Representatives of the reauthorization of the Prescription Drug User Fee Act (PDUFA) today:
